✦ LIBER ✦

EGFR mutations in patients with advanced NSCLC

✍ Scribed by Fiala, Ondrej; Pesek, Milos; Finek, Jindrich; Bruha, Frantisek; Bortlicek, Zbynek; Krejci, Jana; Benesova, Lucie; Minarik, Marek

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMD88 Disparities in Access to EGFR-Muta

✍ L. Kellermann; D. Ukena 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Can mutations of EGFR and KRAS in serum

✍ Seung Tae Kim, Jae Sook Sung, Uk Hyun Jo, Kyong Hwa Park, Sang Won Shin, Yeul Ho 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 300 KB

Efficacy of EGFR tyrosine kinase inhibit

✍ Cho, Su-Hee; Park, Lee Chun; Ji, Jun Ho; Park, Silvia; Hwang, Deok Won; Lee, Ji 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 177 KB

128PD EGFR, KRAS, PIK3CA MUTATIONS AND R

✍ Crinò, L.; Pistola, L.; Bianconi, F.; Chiari, R.; Meacci, M.; Colella, R.; Giuff 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

414 Correlation of mutations in EGFR wit

✍ D. Eberhard; L. Amler; A. Goddard; W. Ince; T. Januario; K. Hillan; M. Ostland; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Retreatment with erlotinib in NSCLC harb

✍ Fiala, Ondrej; Pesek, Milos; Finek, Jindrich; Benesova, Lucie; Minarik, Marek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB